Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0970 per EA under NDC 65862069401. Its NADAC has been published 507 times since Dec 9, 2015.
Strength
250 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862069401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203974On Market Since
5/29/2015
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 507 times since Dec 9, 2015, and over the history we have for it it has declined 59.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0970 per EA |
|---|---|
| All-time high | $0.2777 (Sep 14, 2016) |
| All-time low | $0.0739 (May 22, 2024) |
| 52-week high | $0.1096 |
| 52-week low | $0.0970 |
| Median price | $0.1391 |
| Average price | $0.1595 |
| Largest weekly change | +36.9% (May 22, 2019) |
| Weeks tracked | 507 |
| Tracking since | Dec 9, 2015 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0970 per EA (NDC 65862069401), effective Aug 20, 2025.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 59.5%. It has been tracked across 507 weekly CMS publications since Dec 9, 2015.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Dec 9, 2015, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0739 (May 22, 2024) to a high of $0.2777 (Sep 14, 2016), with a median of $0.1391 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as METRONIDAZOLE 250 MG TABLET, but none are currently priced below it.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 65862069401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification